4 transcripts
RYTM
Earnings call transcript
NASDAQ
2024 Q2
6 Aug 24
that you see what Bardet-Biedl syndrome is.
In the opening session, the head of the foundation charge the attendees with one goal, meet someone
RYTM
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
number, but a number of genes that were of interest. So my goal is to -- we'll give you an update on those 6 genes specifically and tell you how
RYTM
Earnings call transcript
NASDAQ
2023 Q4
22 Feb 24
for these patients is we'll be indifferent. Again, assuming that both of these molecules progress through development, will be indifferent. The goal
RYTM
Earnings call transcript
NASDAQ
2023 Q2
1 Aug 23
a final decision on our weekly strategy pending further development with 718. Our goal quite simply is to develop a better drug, which happens
- Prev
- 1
- Next